Gupta GD - Search Results

1

Recent Progression and Treatment Approaches of Kidney Fibrosis: Evidence to Clinic Approach.

Sharma M, Khanna M, Kumar P, Gupta GD, Sharma K. Sharma M, et al. Among authors: gupta gd. Endocr Metab Immune Disord Drug Targets. 2025 Jun 19. doi: 10.2174/0118715303374764250612052832. Online ahead of print. Endocr Metab Immune Disord Drug Targets. 2025. PMID: 40551698

2

Progression and expansion of ALK inhibitors against NSCLC: A dual target approach.

Kumari S, Akhter M, Gupta GD, Sharma K. Kumari S, et al. Among authors: gupta gd. Eur J Med Chem. 2025 Sep 5;293:117722. doi: 10.1016/j.ejmech.2025.117722. Epub 2025 May 5. Eur J Med Chem. 2025. PMID: 40339471 Review.

3

Recent Progression and Treatment Approaches for the Kidney Stone Management.

Sharma K, Nagpal R, Pandey L, Mittal M, Sharma A, Lal Yadav R, Gupta GD, Sharma K. Sharma K, et al. Among authors: gupta gd. Curr Drug Targets. 2025 May 9. doi: 10.2174/0113894501346592250505050431. Online ahead of print. Curr Drug Targets. 2025. PMID: 40353475

4

Updated insights on ASK1 signaling: mechanisms, regulation, and therapeutic potential in diseases.

Thakur D, Nandi A, Gaur YK, Chandrabose K, Waiker DK, Gupta GD, Sharma K. Thakur D, et al. Among authors: gupta gd. Mol Cell Biochem. 2025 Jun 14. doi: 10.1007/s11010-025-05330-y. Online ahead of print. Mol Cell Biochem. 2025. PMID: 40515958 Review.

5

Green Synthesis of Curcumin Loaded Carbon Dots as a Sustained Drug Delivery for Anticancer Therapy.

Saini A, Nandi A, Gupta GD, Sharma A, Sharma K. Saini A, et al. Among authors: gupta gd. Curr Pharm Des. 2025 Mar 18. doi: 10.2174/0113816128353103250116112919. Online ahead of print. Curr Pharm Des. 2025. PMID: 40108908

6

Integrating Gut-Brain Axis: Exploring the Neurogastrointestinal Interactions and Therapeutic Potentials in Autism Spectrum Disorder.

Kumar M, Mehan S, Sharma T, Kumar A, Khan Z, Sharma AK, Kumar N, Gupta GD. Kumar M, et al. Among authors: gupta gd. Endocr Metab Immune Disord Drug Targets. 2025 Apr 7. doi: 10.2174/0118715303369166250325110016. Online ahead of print. Endocr Metab Immune Disord Drug Targets. 2025. PMID: 40207766

7

The Polygenic Nature of Multiple Sclerosis: Genetic Variants, Immunological Modulation, and Environmental Connections.

Khan Z, Mehan S, Maurya PK, Kumar A, Gupta GD, Narula AS, Kalfin R. Khan Z, et al. Among authors: gupta gd. Endocr Metab Immune Disord Drug Targets. 2025;25(7):527-559. doi: 10.2174/0118715303325979241206115417. Endocr Metab Immune Disord Drug Targets. 2025. PMID: 39810445 Review.

8

A Novel Approach to Refractory Epilepsy by Targeting Pgp Peripherally and Centrally: Therapeutic Targets and Future Perspectives.

Langeh U, Chawla P, Gupta GD, Singh S. Langeh U, et al. Among authors: gupta gd. CNS Neurol Disord Drug Targets. 2020;19(10):741-749. doi: 10.2174/1871527319999200819093109. CNS Neurol Disord Drug Targets. 2020. PMID: 32814543 Review.

9

Recent Progress in Histone Deacetylase (HDAC) 1 Inhibitors as Anticancer Agent.

Patel P, Wahan SK, Vishakha S, Kurmi BD, Gupta GD, Rajak H, Asati V. Patel P, et al. Among authors: gupta gd. Curr Cancer Drug Targets. 2022;23(1):47-70. doi: 10.2174/1568009622666220624090542. Curr Cancer Drug Targets. 2022. PMID: 35747969 Review.

10

Magnetomorph: The Future of Targeted Drug Delivery.

Kumar A, Gupta GD, Kumar M. Kumar A, et al. Among authors: gupta gd. Curr Drug Targets. 2024;25(7):449-453. doi: 10.2174/0113894501309729240414081308. Curr Drug Targets. 2024. PMID: 38639288 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

212 results

Search Page

Filters